Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.
Amr Abdel RaheemMarco CapeceOdunayo M KalejaiyeTarek Abdel-RaheemMarco FalconeMark JohnsonOliver G RalphGiulio GaraffaAndrew N ChristopherDavid J RalphPublished in: BJU international (2017)
The new shortened protocol using CCH treatment is safe, effective, and cost efficient. The results of using only three CCH injections according to this modified protocol are comparable to those of the clinical trials that used eight CCH injections.